These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 16112475)
1. Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain. Totterdell S; Meredith GE Neuroscience; 2005; 135(3):907-13. PubMed ID: 16112475 [TBL] [Abstract][Full Text] [Related]
2. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain. Totterdell S; Hanger D; Meredith GE Brain Res; 2004 Apr; 1004(1-2):61-72. PubMed ID: 15033420 [TBL] [Abstract][Full Text] [Related]
3. Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies. Vivacqua G; Casini A; Vaccaro R; Fornai F; Yu S; D'Este L J Chem Neuroanat; 2011 Mar; 41(2):97-110. PubMed ID: 21172422 [TBL] [Abstract][Full Text] [Related]
4. Perivascular nerve fiber α-synuclein regulates contractility of mouse aorta: a link to autonomic dysfunction in Parkinson's disease. Marrachelli VG; Miranda FJ; Alabadí JA; Milán M; Cano-Jaimez M; Kirstein M; Alborch E; Fariñas I; Pérez-Sánchez F Neurochem Int; 2010 Jul; 56(8):991-8. PubMed ID: 20420875 [TBL] [Abstract][Full Text] [Related]
5. Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: an immunogold electron microscopic study using a C-terminal specific monoclonal antibody. Zhang L; Zhang C; Zhu Y; Cai Q; Chan P; Uéda K; Yu S; Yang H Brain Res; 2008 Dec; 1244():40-52. PubMed ID: 18817762 [TBL] [Abstract][Full Text] [Related]
6. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Schell H; Hasegawa T; Neumann M; Kahle PJ Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424 [TBL] [Abstract][Full Text] [Related]
7. Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. Yavich L; Jäkälä P; Tanila H J Neurochem; 2006 Nov; 99(3):724-32. PubMed ID: 16824047 [TBL] [Abstract][Full Text] [Related]
8. Decreased alpha-synuclein expression in the aging mouse substantia nigra. Mak SK; McCormack AL; Langston JW; Kordower JH; Di Monte DA Exp Neurol; 2009 Dec; 220(2):359-65. PubMed ID: 19800328 [TBL] [Abstract][Full Text] [Related]
9. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Braak H; de Vos RA; Bohl J; Del Tredici K Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147 [TBL] [Abstract][Full Text] [Related]
10. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Chu Y; Kordower JH Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279 [TBL] [Abstract][Full Text] [Related]
11. Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms. Halliday GM; McCann H Exp Neurol; 2008 Jan; 209(1):12-21. PubMed ID: 17706644 [TBL] [Abstract][Full Text] [Related]
12. Role of alpha-synuclein in synaptic glutamate release. Gureviciene I; Gurevicius K; Tanila H Neurobiol Dis; 2007 Oct; 28(1):83-9. PubMed ID: 17689254 [TBL] [Abstract][Full Text] [Related]
13. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Yu S; Li X; Liu G; Han J; Zhang C; Li Y; Xu S; Liu C; Gao Y; Yang H; Uéda K; Chan P Neuroscience; 2007 Mar; 145(2):539-55. PubMed ID: 17275196 [TBL] [Abstract][Full Text] [Related]
14. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Gallardo G; Schlüter OM; Südhof TC Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066 [TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP. Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery. Lee VM; Trojanowski JQ Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225 [TBL] [Abstract][Full Text] [Related]
18. Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats. Miwa H; Kubo T; Suzuki A; Kondo T Neurosci Lett; 2006 Jun; 401(1-2):146-9. PubMed ID: 16600504 [TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptor knockout mice develop features of Parkinson disease. Tinsley RB; Bye CR; Parish CL; Tziotis-Vais A; George S; Culvenor JG; Li QX; Masters CL; Finkelstein DI; Horne MK Ann Neurol; 2009 Oct; 66(4):472-84. PubMed ID: 19847912 [TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Kontopoulos E; Parvin JD; Feany MB Hum Mol Genet; 2006 Oct; 15(20):3012-23. PubMed ID: 16959795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]